BRAF and colorectal carcinoma: Furthermore, the type of cardiotoxicity and the various molecular signaling involved (tyrosine kinase, EGFR, VEGFRs, PDGF, BRAF, mTOR) for promoting the cardiotoxicity in CRC chemotherapy were discussed.